South Korea · Delayed Price · Currency is KRW AptaBio Therapeutics Statistics
Total Valuation
KOSDAQ:293780 has a market cap or net worth of KRW 126.28 billion. The enterprise value is 115.47 billion.
| Market Cap | 126.28B |
| Enterprise Value | 115.47B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:293780 has 28.09 million shares outstanding. The number of shares has increased by 6.50% in one year.
| Current Share Class | 28.09M |
| Shares Outstanding | 28.09M |
| Shares Change (YoY) | +6.50% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 27.22% |
| Owned by Institutions (%) | n/a |
| Float | 19.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.57 |
| PB Ratio | 2.99 |
| P/TBV Ratio | 3.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 24.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.54 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.03 |
Financial Efficiency
Return on equity (ROE) is -33.15% and return on invested capital (ROIC) is -22.73%.
| Return on Equity (ROE) | -33.15% |
| Return on Assets (ROA) | -18.89% |
| Return on Invested Capital (ROIC) | -22.73% |
| Return on Capital Employed (ROCE) | -41.21% |
| Weighted Average Cost of Capital (WACC) | 9.90% |
| Revenue Per Employee | 108.03M |
| Profits Per Employee | -337.93M |
| Employee Count | 44 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 4.42 |
Taxes
In the past 12 months, KOSDAQ:293780 has paid 1.01 billion in taxes.
| Income Tax | 1.01B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.09% in the last 52 weeks. The beta is 0.90, so KOSDAQ:293780's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -39.09% |
| 50-Day Moving Average | 6,259.50 |
| 200-Day Moving Average | 6,388.45 |
| Relative Strength Index (RSI) | 26.63 |
| Average Volume (20 Days) | 68,150 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:293780 had revenue of KRW 4.75 billion and -14.87 billion in losses. Loss per share was -540.42.
| Revenue | 4.75B |
| Gross Profit | 2.24B |
| Operating Income | -18.75B |
| Pretax Income | -13.86B |
| Net Income | -14.87B |
| EBITDA | -18.32B |
| EBIT | -18.75B |
| Loss Per Share | -540.42 |
Balance Sheet
The company has 15.73 billion in cash and 4.91 billion in debt, with a net cash position of 10.81 billion or 384.86 per share.
| Cash & Cash Equivalents | 15.73B |
| Total Debt | 4.91B |
| Net Cash | 10.81B |
| Net Cash Per Share | 384.86 |
| Equity (Book Value) | 42.20B |
| Book Value Per Share | 1,502.15 |
| Working Capital | 13.68B |
Cash Flow
In the last 12 months, operating cash flow was -17.37 billion and capital expenditures -30.87 million, giving a free cash flow of -17.40 billion.
| Operating Cash Flow | -17.37B |
| Capital Expenditures | -30.87M |
| Depreciation & Amortization | 435.38M |
| Net Borrowing | -180.71M |
| Free Cash Flow | -17.40B |
| FCF Per Share | -619.49 |
Margins
| Gross Margin | 47.21% |
| Operating Margin | -394.52% |
| Pretax Margin | -291.66% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:293780 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.50% |
| Shareholder Yield | -6.50% |
| Earnings Yield | -12.02% |
| FCF Yield | -13.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on August 24, 2021. It was a forward split with a ratio of 2.
| Last Split Date | Aug 24, 2021 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
KOSDAQ:293780 has an Altman Z-Score of 6.24 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.24 |
| Piotroski F-Score | 3 |